Recommendations for standardization of laboratory testing for drug-induced immune thrombocytopenia: communication from the SSC of the ISTH

Documenti analoghi

• Recommendations for the use of NOD/SCID mouse model in autoimmune- and drug-induced thrombocytopenia: communication from the SSC of the ISTH
  di: Bakchoul, Tamam, et al.
  Pubblicazione: (2015)
• Recommendations for the clinical and laboratory diagnosis of VITT against COVID‐19: Communication from the ISTH SSC Subcommittee on Platelet Immunology
  di: Nazy, Ishac, et al.
  Pubblicazione: (2021)
• Recommendations for the implementation of platelet autoantibody testing in clinical trials of immune thrombocytopenia
  di: ARNOLD, D.M., et al.
  Pubblicazione: (2012)
• COVID‐19 coagulopathy in pregnancy: Critical review, preliminary recommendations, and ISTH registry—Communication from the ISTH SSC for Women’s Health
  di: Kadir, Rezan Abdul, et al.
  Pubblicazione: (2020)
• A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia
  di: ARNOLD, D. M., et al.
  Pubblicazione: (2013)